Older adults · Illinois
Studies for adults 50 and older in Illinois
These studies set a minimum age of 50 or older in their official record. Many look at conditions more common with age, and some vaccine and memory studies specifically need older participants.
48 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 3
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
Adverum Biotechnologies, Inc.
- Location
- Chicago, IL + 78 other US sites
- Eligibility basics
- Ages 50+
- RecruitingPhase 2
A Phase IIb Randomized, Multicenter Trial of Subretinal CPCB-RPE1 in Advanced Dry AMD (Geographic Atrophy)
Regenerative Patch Technologies, LLC
- Location
- Lemont, IL + 4 other US sites
- Eligibility basics
- Ages 55–90
- RecruitingPhase 2
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
ONL Therapeutics
- Location
- Chicago, IL + 55 other US sites
- Eligibility basics
- Ages 55+
- RecruitingPhase 1
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
Astellas Institute for Regenerative Medicine
- Location
- Oak Forest, IL + 12 other US sites
- Eligibility basics
- Ages 50+
- Recruiting
Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration
i-Lumen Scientific AUS PTY LTD
- Location
- Lemont, IL + 5 other US sites
- Eligibility basics
- Ages 60+
- RecruitingPhase 1/Phase 2
4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
4D Molecular Therapeutics
- Location
- Oak Forest, IL + 19 other US sites
- Eligibility basics
- Ages 50+
- RecruitingPhase 3
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
Amgen
- Location
- Arlington Heights, IL + 193 other US sites
- Eligibility basics
- Ages 50–105
- RecruitingPhase 2/Phase 3
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
EyeBiotech Ltd.
- Location
- Joliet, IL + 51 other US sites
- Eligibility basics
- Ages 50+
- RecruitingPhase 2
Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degeneration
Adverum Biotechnologies, Inc.
- Location
- Lemont, IL + 11 other US sites
- Eligibility basics
- Ages 50+
- RecruitingPhase 3
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Anthos Therapeutics, Inc.
- Location
- Park Ridge, IL + 131 other US sites
- Eligibility basics
- Ages 65+
- RecruitingPhase 3
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
Eli Lilly and Company
- Location
- Chicago, IL + 41 other US sites
- Eligibility basics
- Ages 55+
- RecruitingPhase 2/Phase 3
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study
Kardigan, Inc.
- Location
- Chicago, IL + 46 other US sites
- Eligibility basics
- Ages 50+
- RecruitingPhase 2
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in…
Apellis Pharmaceuticals, Inc.
- Location
- Oak Park, IL + 77 other US sites
- Eligibility basics
- Ages 60+
- Recruiting
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
Edwards Lifesciences
- Location
- Chicago, IL + 49 other US sites
- Eligibility basics
- Ages 65+
- RecruitingHealthy volunteersPhase 4
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
Duke University
- Location
- Chicago, IL + 88 other US sites
- Eligibility basics
- Ages 75+
- RecruitingHealthy volunteers
BRIDGE & Friends Trial
University of Illinois at Chicago
- Location
- Chicago, IL
- Eligibility basics
- Ages 50–79
- RecruitingHealthy volunteers
LUNG-07: Advancing Precision-Based Lung Cancer Screening: Implementation, AI-Guided Risk Stratification, and Biomarker Integration (CREST AI)
University of Illinois at Chicago
- Location
- Chicago, IL + 1 other US site
- Eligibility basics
- Ages 50–80
- RecruitingHealthy volunteers
Dual Task Perturbation Training for OAwMCI
University of Illinois at Chicago
- Location
- Chicago, IL
- Eligibility basics
- Ages 55+
- RecruitingHealthy volunteers
Digital Tools to Support Healthcare Decision Making
Weill Medical College of Cornell University
- Location
- Champaign, IL + 1 other US site
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteers
Late Onset Alzheimer's Disease
Columbia University
- Location
- Aurora, IL + 11 other US sites
- Eligibility basics
- Ages 55+
- RecruitingHealthy volunteers
Exercise and Protein Efficiency in T2D
University of Illinois at Urbana-Champaign
- Location
- Urbana, IL
- Eligibility basics
- Ages 65+
- RecruitingHealthy volunteers
The SENTINL-1 Study: Evaluating Patient-Reported Outcomes of AI-Inferred Lung Cancer Risk
University of Illinois at Chicago
- Location
- Chicago, IL
- Eligibility basics
- Ages 50–80
- RecruitingHealthy volunteers
Noradrenergic Dysregulation, Sleep and Cognition in Older Adults With Insomnia
Northwestern University
- Location
- Chicago, IL
- Eligibility basics
- Ages 55+
- RecruitingHealthy volunteers
Lung Cancer Screening in High-risk Black Individuals
Massachusetts General Hospital
- Location
- Chicago, IL + 1 other US site
- Eligibility basics
- Ages 50–80